JP Morgan Chase’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
SCM
JP Morgan Chase's EIKN Position: Q3 2026 in Review
JP Morgan Chase increased its Eikon Therapeutics (EIKN) stake by 452% in Q3 2026, buying an estimated $469K and bringing the position to 56,951 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #5295.
JP Morgan Chase first reported a position in EIKN in Q1 2026 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.
- JP Morgan Chase held 56,951 shares of Eikon Therapeutics worth $450K as of Q3 2026.
- JP Morgan Chase bought 46,627 Eikon Therapeutics shares in Q3 2026, an estimated $469K.
- Eikon Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #5295 holding.
- JP Morgan Chase first reported a position in Eikon Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 74 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.